![Sierk Poetting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sierk Poetting
Chief Operating Officer at
BIONTECH SE
Net worth: 52 M $ as of 2026-05-30
Profile
Currently, Sierk Pötting occupies the position of Chief Operating & Financial Officer for BioNTech SE and Co-Managing Director at JPT Peptide Technologies GmbH and Managing Director at BioNTech Small Molecules GmbH (both are subsidiaries of BioNTech SE). In the past Dr. Pötting held the position of VP & Chief Financial Officer-Sandoz Division at Novartis AG and Chief Financial Officer & Vice President for Sandoz, Inc. (a subsidiary of Novartis AG) and Consultant at McKinsey GmbH & Co. KG. He received a graduate degree from the University of Arizona and a doctorate from Ludwig-Maximilians-Universität München.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIONTECH SE 0.22% | 2026-05-11 | 542,539 ( 0.22% ) | 52 M $ | 2026-05-30 |
Sierk Poetting active positions
| Companies | Position | Start |
|---|---|---|
| BIONTECH SE | Chief Operating Officer | 2014-08-31 |
JPT Peptide Technologies GmbH
 JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology Provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery | Chief Executive Officer | - |
BioNTech Europe GmbH
 BioNTech Europe GmbH BiotechnologyHealth Technology Engages in the research and development of synthetic compounds against cancer and other diseases | Chief Executive Officer | - |
IQM Finland Oy
 IQM Finland Oy Computer Processing HardwareElectronic Technology Develops quantum computers | Chairman | 2022-03-02 |
BioNTech Diagnostics GmbH
 BioNTech Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops peptide synthesis solutions | Chief Executive Officer | - |
BioNTech Delivery Technologies GmbH
 BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies | Chief Executive Officer | - |
Former positions of Sierk Poetting
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 2014-07-31 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Director of Finance/CFO | - |
McKinsey GmbH & Co. KG
 McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Corporate Officer/Principal | - |
Training of Sierk Poetting
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JPT Peptide Technologies GmbH
JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology Provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery | Health Technology |
BioNTech Diagnostics GmbH
BioNTech Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops peptide synthesis solutions | Commercial Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
McKinsey GmbH & Co. KG
McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
BioNTech Europe GmbH
BioNTech Europe GmbH BiotechnologyHealth Technology Engages in the research and development of synthetic compounds against cancer and other diseases | Health Technology |
IQM Finland Oy
IQM Finland Oy Computer Processing HardwareElectronic Technology Develops quantum computers | Electronic Technology |
BioNTech Delivery Technologies GmbH
BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies | Commercial Services |
- Stock Market
- Insiders
- Sierk Poetting
